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ABSTRACT 
Derivatives of cyclohexanol and cyclohexylamine were pharma-
cologically screened for cardioplegic effects on intact anesthetized 
rats, and isolated guinea pig hearts. Evaluation of potency was based 
on the ability to depress rat carotid blood pressure, and to produce 
cardiac arrest in the isolated guinea pig heart. 
As a group, the non-ethynyl cyclohexanol derivatives were more 
potent in producing a hypotensive response, than were the derivatives 
of cyclohexylamine. trans-2-£-Tolyl-cis-l, 4-cyclohexanediol and 
trans-2-£-tolyl-trans-l, 5-cyclohexanediol were equally effective and 
the most active. trans-2-(E.-Chlorophenyl)-N, N-dimethylcyclohexyl~ 
amine was the least active, and the only compound to produce a pressor 
response. 
Conversely, the cyclohexylamines were more potent cardioplegic 
agents. The cis and trans isomers of 2-(E.-chlorophenyl)-N, N-dimethyl 
cyclohexylamine were equally the most active with trans-2-£-tolyl-
cis-l, 4-cyclohexanediol the least active. The minimum effective car-
dioplegic dose of l-ethynyl-trans-2-£-tolylcyclohexanol was also the 
cardiotoxic dose as the heart failed to recover from arrest. 
Mechanism studies on spontaneously beating isolated rat atria 
indicate an antagonistic effect between calcium and the negative 
inotropic action of these compounds. 
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I. INTRODUCTION 
Today, "open-heart" surgery has changed the outlook for a great 
many cardiac patients, particularly those having congenital defects, 
which would have been labeled as hopeless cases slightly more than 
ten years ago. The performance of the first successful "open-heart" 
or direct vision operation in this country, was reported by Lewis and 
Taufic in 1953. 
In the years that followed, many valuable adjuncts to direct 
vision surgery have been developed. For example, the use of plastic 
patches and valves to replace missing or damaged tissues in the heart; 
and the fully mechanical heart-lung machine as reported by Gibbon in 
1954. By utilizing the heart-lung machine, the surgeon is able to 
interrupt the function of the heart and lungs at the expense of the ma-
chine, which does the pumping for the heart and conducts the pulmo -
nary exchange of oxygen and carbon dioxide; an extracorporeal circu-
lation. 
Another important aid in the surgical treatment of intracardiac 
defects, is the still heart. Under certain conditions, where a dry, 
motionless and clearly visible operative field is desirab le, an arrested 
and all-but-bloodless heart enables the surgeon to repair more accur -
ately a particular defect. 
Elective cardiac arrest has been experimentally and clinically 
8 
produced by several methods. These consist chiefly of inducing arrest 
by hypothermia, myocardial anoxia, pharmacological agents, or a 
combination of any or all three. Since this investigation deals with the 
pharmacological approach to elective cardiac arrest, the review of the 
literature will be confined accordingly. 
Other methods such as total body hypothermia, local cooling of 
the heart, and myocardial anoxia appear to be fa vored at present over 
known methods of chemical cardioplegia. One reason for this, is the 
apparent unlikeliness that the 11 ideal11 cardioplegic agent or combina -
tion of agents has been found. According to Stephenson (1964), such 
an agent should have a prompt and complete effect of proper duration, 
be free from toxicity, and characterized by a completely reliable re-
covery period. 
In 1959 Huitric et al. , reported that 2-(~-tolyl)-cyclohexanol was 
capable of producing reversible cardiac arrest, without affecting myo-
cardial electrical properties. This finding stimulated the preparati on 
of a number of substituted cyclohexanol derivatives by Huitric. 
Previous pharmacologic evaluation studies by Smookler and DeFeo 
( 1962) and Smith (1963) showed the degree of cardio-inhibitory activity 
to be related to the functional groups and stereochemistry of these 
compounds. 
In continuation, therefore, the present investigation was carried 
9 
out on additional compounds prepared by Huitric, in an effort to deter-
mine their possible cardio-inhibitory activity, and its relationship to 
molecular structure. 
II. REVIEW OF THE LITERATURE 
Perhaps the first to draw attention to the effect of the various 
cations on the heart beat, was Ringer (1882). While performing 
heart perfusion experiments, he noted that the addition of small 
quantities of potassium chloride to the perfusing fluid resulted in 
diastolic ventricular arrest. Again in 1883, Ringer described the 
antagonism existing in heart muscle between calcium and potassium 
salts; an excess of calcium resulted in "fusion of the beats" or 
systolic arrest, whereas increased amounts of potassium weakened 
the beat and diastolic arrest ensued. 
In an effort to restore normal rhythm to the fibrillating ven-
tricles of the dog, Hooker ( 1929} showed that potassium chloride 
produced cardiac arrest when injected under pressure into the 
carotid artery toward the heart. Normal rhythm was then restored 
upon the injection of calcium by the same route. 
Thus was laid the real foundation for the production of elec-
tive cardiac arrest by chemical means. To date, only the potassium 
salts and acetylcholine have achieved any status as cardioplegic 
agents. 
Senning (1952) was able to stop cardiac contractions for a brief 
period using methacholine, acetylcholine, and potassium chloride. 
However, he was unsuccessful in producing prolonged asystole, as 
10 
coronary perfusion was maintained which quickly washed out the 
cardioplegic ions. 
Lam and his a .ssociates (1955) used 5 per cent potassium 
chloride injected into the dog's left ventricle and produced cardiac 
arrest for periods of ten to thirty minutes. During the recovery 
period a high incidence of ventricular fibrillation occurred and nine 
of ten arrested hearts were restored to normal rhythm by counter-
shock. 
11 
Melrose et al. (1955), working with potassium citrate, produced 
cardiac arrest in isolated rabbit, guinea pig, and kitten hearts. More-
over, he instituted the 11 Melrose 11 technique for producing asystole. 
An injection of a mixture of potassium citrate and aspirated whole 
blood into the base of the cross-clamped aorta, resulted in diastolic 
arrest of the heart. Arrest was maintained as long as an adequate 
level of potassium citrate remained in the coronary arteries, and 
normal rhythm was restored when simple perfusion of the coronary 
circulation reduced the concentration of potassium citrate. 
Baker and Dreyer (1956) found it possible to stop the same 
isolated heart ten times for at least fifteen minute periods, each with 
coronary flow interrupted. In control hearts, without potassium cit-
rate the hearts recovered poorly. They reported that no antagonist 
to potassium citrate was needed to restore the beat, just normal 
perfusion. Moreover, the proportions of potassium and citrate in 
potassium citrate itself were the best for causing complete cardiac 
arrest without persistent ventricular fibrillation. 
Bentall and Melrose (1957) in studying the production of lactic 
acid in isolated perfused hearts after varying periods of arrest, 
reported that potassium citrate did offer some protection against its 
anaerobic build up. 
Using the technique of Melrose, Kol££ et al. (1956) reported 
12 
ventricular fibrillation in only one of ten dogs with cardiac arrest up 
to twenty-three minutes, and Effler et al. (1956) successfully treated 
two of three cases of congenital heart disease with the heart resuming 
normal sinus rhythm in all three cases. However, following thirty-
seven open-heart operations, Kolff et al. (1957) reported that with 
potassium citrate, cardiac arrest as long as forty minutes had been 
attained. Ventricular fibrillation had occurred; but was restored to 
normal sinus rhythm in seven instances. It was suggested that 
higher perfusion rates might increase the speed with which the heart 
beat recovers after potassium citrate, and thus might reduce the inci-
dence of temporary arrhythmias. Effler et al. (1957) also observed 
ventricular fibrillation frequently in reporting on the clinical feasi-
bility of the 11 Melrose 11 technique as an aid to open-heart surgery. 
Meanwhile, acetylcholine began to be used by other investigators 
13 
as a cardioplegic agent. Previously, Bjork (1948) had been unsuccess-
ful in stopping the heart with acetylcholine in at least one experiment 
on the dog. However, acetylcholine was shown by Sergeant et al. 
(1956) to be a safe and effective cardioplegic agent for both the hypo -
thermic and normothermic dog heart . They reported similar success 
in a series of eight human open-heart operations. Moulder et al. 
(1956) also reported success in the use of acetylcholine to inhibit 
cardiac contractions in dog and humans under hypothermia. 
Lam et al. (1957, 1957a, 1958), using acetylcholine as the car-
dioplegic agent, reported on its clinical safety and low incidence of 
ventricular fibrillation during recovery. It was noted however, that 
during arrest with acetylcholine the heart might beat if the ventricle 
wall was stimulated mechanically by forceps or needles. 
Despite the success reported with the use of acetylcholine, 
interest remained in the "Melrose" technique of elective cardiac 
arrest with potassium citrate. Kaplan et al. (1958) called attention 
to a high incidence of ventricular fibrillation following the use of the 
"Melrose" technique in dogs. In sustaining a 50 per cent mortality 
rate with this method the authors suggested that the ideal drug for 
cardioplegia should have a known and predictable reversible effect. 
Helmsworth et al. (1958) reported that the high incidence of 
refractory ventricular fibrillation following potassium citrate ar rest 
might be due to the high concentration of potassium in blood taken 
from the left atrium. This was in contrast to only a slight rise in 
atrial potassium concentration following acetylcholine arrest. 
In an effort to overcome the ventricular fibrillation associated 
with the "Melrose" technique of cardiac arrest, Milnes et al. (1958) 
combined potassium citrate with magnesium sulfate in arresting the 
dog heart. The combination appeared to have a synergistic effect. 
Consistent survival, with no fibrillation was reported in animals 
undergoing cardiac arrest for thirty-five minutes or less. 
In a similar approach Sealy et al. (1958) and Merritt et al. 
(1958) used a combination of potassium citrate, magnesium sulfate, 
and neostigmine. The protective action of neostigmine depends in 
part on the production of acetylcholine which in turn depends on the 
concentration of ATP. Baer et al. (1956) had shown that the pro-
tective action of neo stigmine alone against ventricular fibrillation 
was less when the coronary ostia were occluded, presumably be-
cause of the low concentration of ATP resulting from anaerobic 
glycolysis. 
It was at this time that several investigators began measuring 
myocardial depression associated with elective cardiac arrest. 
Weirich et al. (1959) observed that the ability of the ventricles to 
perform work was better following acetylcholine induced asystole, 
14 
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than with potassium citrate. Willman et al. (1959, l 959a) reported 
that thirty minutes of cardiac arrest induced by potassium citrate, 
acetylcholine, and a mixture of potassium citrate, magnesium sulfate, 
and neostigmine severely impaired the ability of the canine heart to 
do work as determined by the profound decrease in cardiac output and 
cardiac stroke work. The authors suggested the use of cardiotonic 
agents to lower the demands on cardiac output and increase work 
capacity during the post-operative period. 
Accordingly, Cooper et al. (1959) studied left ventricular func -
tion in dogs. The cardiotonic agent mephentermine was used post-
operatively where there was evidence of severe myocardial depres-
sion following thirty minutes of elective cardiac arrest with potassium 
citrate. It was indicated that mephentermine might be useful in the 
post-operative management of subjects who had undergone extended 
periods of cardiac arrest. Moreover, in similar studies by the same 
authors (1959a, 1960) it was shown that hypothermia and also predigital -
ization offered partial protection to the canine myocardium subjected 
to thirty minutes of arrest with potassium citrate. 
A method for prolonging induced cardioplegia was proposed by 
Headrick et al. (1959). Initial cardiac arrest was obtained by inject-
ing a 2. 5 per cent potassium citrate in saline into the base of the 
canine aorta. The coronaries were then cannulated with self 
16 
containing Manlove cannulae and continuously perfused with oxygenated 
blood containing the cardioplegic agent potassium citrate. Perfusate 
was drained from a right atrial cannula and returned to a purnp-
oxygenator system. After three hours of cardiac arrest produced in 
this manner, all of the hearts could maintain a normal rhythm after 
extracorporeal circulation was discontinued. 
Kaplan and Fisher (1959) studied the metabolism and fate of 
t . d d' 1 . t U . K 42 . ' t t po as s1um use as a car iop eg1c agen . sing -potas s1um c1 ra e 
in both normothermic and hypothermic dogs, reversibility of cardio-
plegia did not seem to be related to the amount of potassium injected 
or to its concentration in the myocardium. The washing out of potas-
sium and the resumption of normal rhythm were not synonymous, 
and the mortality in normothermic dogs was less than that of hypo-
thermic animals. With predigitalization the mortality of the latter 
group was significantly reduced. Most of the radioactive potassium 
was found in the middle third of the interventricular septum, perhaps 
explaining the relatively high incidence of ventricular fibrillation 
following its use. The authors thus suggested that the safety of a 
future cardioplegic agent might well depend upon there being a specific 
anti-cardioplegic drug. Such a compound should be equally effective in 
re-establishing a normal physiologic state. 
In an effort to combine local hypothermia with chemical 
17 
cardioplegia, Kenyon et al. (1959) administered potassium citrate and 
acetylcholine with the infusate temperature at 4°C or 5°C. Cardiac 
arrest occured in only 40 per cent of the animals t r eated with acetyl-
choline compared to 100 per cent of those injected with potassium 
citrate. They concluded that the only reliable means of producing 
complete cardiac arrest was with the combination of potassiurn citrate 
and cold infusate. 
Biopsies taken from human hearts before, during, and at the end 
of potassium citrate arrest and arrest produced by cooling coronary 
blood to about 10°C, were analyzed by Gott et al. (1959) for various 
energy substances. The levels of ATP, phosphocreatine and glycogen 
fell much more rapidly following potassium citrate arrest, than follow-
ing selective hypothermic arrest. Also, tissue lactic acid rose more 
rapidly with potassium citrate arrest. It was concluded that arrest 
brought about by selective hypothermia was far superior to arrest by 
potassium citrate for the maintenance of myocardial energy resources. 
Dodrill and Takagi ( 1960) showed that the addition of ATP to 
potassium citrate arrest mixture allowed a much longer time of anoxic 
metabolism and enabled the heart to utilize oxygen better in the post 
arrest period. 
The studies of Redo (1959) and Redo and Porter (1959), showed 
oxygen to be a more important factor upon the reversibility of 
myocardial function after arrest, than was glucose. Furthermore, 
Redo believed arrest produced by the accumulation of endogenous 
potassium was reversible, while that produced by lack of oxygen, 
energy substrate (glucose) or both was not reversible. 
In an effort to lower oxygen consumption of the arrested heart, 
without having to use hypothermia, Clark et al. (1959) perfused the 
heart with hypocalcemic arterialized blood . The heart so perfused 
in situ with cardiopulmonary by-pass, recovered from forty-five 
minutes of arrest, with no gross evidence of damage. 
Myocardial necrosis was reported by McFarland et al. (1960) 
18 
in 79 per cent of patients who had undergone potassium citrate cardiac 
arrest and who had died at various intervals following open heart 
surgery. The lesion was not observed in the hearts of patients who 
underwent similar procedures without arrest or with anoxic arrest. 
The authors stated that these findings led to the abandonment of the 
''Melrose" technique at the National Heart Institute. 
Yashar et al. ( 1960) felt that none of the cardioplegic agents 
they used in dog experiments, appeared safe for routine clinical use. 
Recovery from arrest by potassium citrate, acetylcholine, sodium 
citrate, sodium phytate, methacholine, and potassium chloride was 
accompanied by a high incidence of ventricular fibrillation. More-
over, no relationship was observed between the dose of a particular 
19 
agent, the duration of cardiac arrest or the rate of recovery. 
In evaluating the effect of potassium and magnesium ions used 
to arrest the isolated perfused rabbit heart, Mouritzen and Albrechtsen 
( 1960), concluded that both ions were capable of induc ing controlled 
arrest; but that the toxic effect of magnesium was higher than that of 
potassium. After exposure to magnesium, arrhythmias were more 
frequent and the reduction in amplitude of contraction was greater than 
after similar exposure to potassium. Further work by these investi-
gators (1961) re-emphasized the injurious effect of the magnesium ion 
and to a lesser degree the potassium ion, on the isolated heart. Reduc-
tion of the temperature from 3 7°C to 29° C protected the isolated heart 
to a certain extent, from the injurious effects caused by the ions , as 
well as those caused by a deficiency in oxygen. It was noted that the 
withdrawal of oxygen administration for sixty minutes during total 
cardiac arrest appeared to damage the heart more than continued 
administration of potassium ions for an equivalent time. Moreover; 
at 37°C, the heart did not recover from sixty minutes of potassium 
citrate arrest, while at 29°C recovery was accompanied by a consid-
erable decrease in the amplitude of contraction. 
Kusinoki et al. (1960) studied the ventricular performance of 
dogs having undergone acetylcholine, potassium citrate, and hypoxic 
cardiac arrest in the normothermic and hypothermic states. Cardiac 
20 
arrest for fifteen minutes by any method resulted in depression of 
myocardial function of 50 to 70 per cent of control function. At normal 
body temperature, recovery appeared to be most rapid after potassium 
citrate and most delayed after hypoxia. Hypothermia partially pro-
tected the hypoxic heart and in comparison with the other methods 
studied, cardioplegia by this technique resulted in the least depres-
sion and best recovery of myocardial function. Bjork and Fors (1961) 
preferred using deep hypothermia to potassium citrate, acetylcholine 
or hypoxia as a method of producing cardiac arrest. Oxygen demands 
were diminished and fewer pathologic changes in the myocardium were 
observed during this type of arrest. 
Parker et al. (1961), McKain et al. (1961), and Bhonslay et al. 
(1961) all reported difficulty in obtaining satisfactory cardiac arrest 
with acetylcholine. Each group observed ventricular fibrillation fol-
lowing its use. The latter investigators in comparing acetylcholine, 
carbachol, and potassium citrate cardioplegia, concluded potassium 
citrate to be the only agent that consistently produced almost imme-
diate cardiac arrest. 
Miller et al. (1961) compared the effect of cardiac arrest by 
potassium citrate, anoxia, and a combination of anoxia with local hypo-
thermia on myocardial structure and function. The changes in heart 
function following potassium citrate arrest, although severe, were 
21 
less than those observed in other groups. Glycogen was preserved 
better in hearts arrested by potassium citrate than in those arrested 
by anoxia with or without local hypothermia. There was however , 
extensive myocardial necrosis following one hour of potassium citrate 
arrest. Gross and microscopic areas of necrosis were again observed 
by Miller et al. (1964) in dog hearts twenty-four to forty-eight hours 
following recovery from potassium citrate arrest. In contrast, no 
morphologic changes were noted immediately after cardiac arrest by 
profound hypothermia with or without coronary perfusion. Irrevers-
ible degenerative lesions were demonstrated however, in the heart 
cells of 50 per cent of the surviving animals regardless of the type of 
arrest or its duration. 
Isolated perfused guinea pig hearts were subjected to prolonged 
periods of cardioplegia by Redo (1962). Mechanical recovery of 83 to 
100 per cent followed arrest up to periods of sixty minutes achieved by 
the use of potassium citrate plus magnesium sulfate, or hypothermia. 
Anoxic arrest lead to the poorest return of cardiac action as compared 
with the other methods used. Fibrillation during recovery, occurred 
in all instances after prolonged periods of cardioplegia except when 
arrest was achieved by hypothermia. A direct relationship existed 
between the duration of arrest and the length of time the heart took to 
recover. Similarly, mechanical recovery was poorer following 
prolonged cardioplegia. 
Kaplan and Fisher (1962) proposed that the incorporation of 
potassium into the myocardium might be related to the carrier used 
to transport the ion. The potassium vehicles used were whole blood, 
50 per cent glucose in water, 10 per cent glucose in saline, and iso-
tonic saline. Survival was highest and fibrillation was lowest when 
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10 per cent glucose in saline was used; and although whole blood is 
widely used as a vehicle, results with this carrier ""."ere considered 
unsatisfactory. A more satisfactory recovery of the heart was believed 
to accompany the maintenance of myocardial cell feactivity by proper 
nutrition (glucose) and the presence of the sodiupi ion. 
In evaluating potassium citrate, anoxic and hypothermic cardio-
plegia in patients treated with open heart surgery , Brewer et al. ( 1962) 
found hypothermic arrest to be superior. The mortality figure was 
highest following the use of potassium citrate, and lowest after hypo -
thermic arrest. Microscopic sections of myocardium removed from 
patients not surviving, showed degeneration to be more severe after 
potassium citrate or anoxic arrest. 
Burdette and Al-Shamma (1962) reported a decrease in myocardial 
ATP and a concommitant increase in ADP and AMP during normo-
thermic hypoxic or potassium citrate arrest accompanied by cardio-
pulmonary by-pass. These metabolic changes during arrest were not 
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0 prevented by a temperature of 2 7 C, even though recovery appeared 
to be facilitated by hypothermia. 
Previously, Gott et al. (1959) observed that the canine heart 
arrested with potassium citrate or by anoxia developed complete 
rigor mortis when the level of ATP fell to the range of 15 per cent 
of its initial value. Gott et al. (1962) suggested that by determining 
the "Time of Rigor" with different methods of cardiac arrest, an 
investigator could obtain an approximation of the myocardial protec -
tion associated with a particular arresting technique. In measuring 
rigor with a special intramuscular pressure-sensor device developed 
by the authors, a correlation was observed between the time of com-
plete rigor and the level of myocardial ATP. Both the normothermic 
and the moderately hypothermic heart arrested by potassium citrate 
or anoxia showed good correlation between the time of complete rigor 
and the myocardial ATP level. 
More recently however, with respect to adenine nucleotide 
changes, Berne et al. ( 1964) were unable to show any significant dif-
ference between the potassium citrate arrested heart and the heart 
arrested by selective hypothermia. These findings ar e in contrast to 
those previously reported by Gott et al. (1959) . 
The amount of conflicting data that exists regarding the evalu-
ation of cardioplegic agents appears to be related to the variety in the 
methods of comparison used. These have ranged from over-all sur-
vival results to tissue acidosis and oxygen consumption determina-
tions; from histologic changes to mere recovery and contractility of 
the heart. 
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Recent literature pertaining to cardiac arrest and its use as an 
adjunct in open heart surgery indicates that hypothermia is presently 
favored over all other methods used to arrest the heart. Nevertheless, 
the search continues for the "ideal" cardioplegic agent possessing the 
aforenamed qualities and a uniform dose-response relationship. 
Nelson and his associates (1958) in discussing the progress made 
rn evaluating possible cardioplegic agents , reported that although 
recovery was unsuccessful, 2-(~-methylphenyl) cyclohexanol was 
capable of producing cardiac arrest in the dog. Huitric et al. (1959) 
noted that in isolated cat hearts, this compound produced reversible 
mechanical arrest. The complete absence of arterial pres sure observed 
in the intact dog, following its injection was presumed by the authors to 
be due in part to depressed ventricular contraction. 
These findings prompted Huitric to prepare a number of substi-
tuted cyclohexanol and cyclohexane derivatives. The specificity of 
functional groups, and structure-activity relationships associated with 
compounds producing reversible cardiac arrest served as guide-lines 
for further synthetic development. 
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Previous studies showed that certain of the compounds possess 
potential as cardioplegic agents. Cyclohexanol and its 2-aryl deriva-
tives were investigated by Smookler and DeFeo (1962). All of the 
compounds were capable of producing an immediate drop in rat blood 
pressure, while the trans isomers of the (~-tolyl) and (~-chlorophenyl) 
compounds were the most effective in producing cardio-inhibitory 
effects on the isolated guinea pig heart. In preliminary mechanism 
studies, trans-2-£-tolylcyclohexanol antagonized the effect of the 
calcium ion on isolated rabbit atria. In unpublished experiments em-
ploying extracorporeal circulation, Smookler ( 1961) noted that although 
ventricular fibrillation and incompetent myocardial contractions were 
the major problems following arrest of the dog heart, recovery was 
faster and more consistent with trans-2-£-tolylcyclohexanol than with 
trans-2-~- chlorophenylcyclohexanol. 
Derivatives of cyclohexylamine and cyclohexane were evaluated 
similarly. Unpublished work of Smith (1963) showed tr~-2-.£_­
tolylcyclohexylamine to be the most active in its series. 2-£-tolyl-
cyclohexen-2-one was the most active of the miscellaneous cyclo-
hexane derivatives tested. 
The present investigation of additional cyclohexanol and cyclo-
hexylamine derivatives prepared by Huitric was carried out in an 
effort to further correlate molecular structure with cardio-inhibitory 
activity. 
III. INVESTIGATION 
A. OBJECTIVES 
Recent reports found in the literature indicate that certain sub-
stituted cyclohexanes are capable of inhibiting the cardiovascular 
system. Indeed, other investigators have shown that cyclohexanol 
and its 2-aryl derivatives, produced varying degrees of cardiac inhi-
bition. Moreover, similar unpublished results were obtained with 
substituted cyclohexylamine s, and miscellaneous cyclohexane de riv-
atives. 
This investigation was therefore, undertaken to determine the 
possible cardio-inhibitory effects of additional cyclohexanol and 
cyclohexylamine derivatives. 
The objectives of the investigation were as follows: 
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1. To screen pharmacologically a series of synthetic chemical 
compounds for cardioplegic and hypotensive characteristics. 
2. To relate the activity to the structured arrangement of the 
compounds screened. 
3. To attempt to determine the mechanism through which these 
compounds act. 
B. THE COMPOUNDS 
The cyclohexanol and cyclohexylamine derivatives used were 
synthesized by Dr. Alain C. Huitric of the Department of 
Pharmaceutical Chemistry, University of Washington, College of 
Pharmacy, Seattle, Washington. The cyclohexylamine hydrochloride 
salts (Fig. 1) were freely soluble in water. The ethynyl derivatives 
of cyclohexanol (Fig. 2) were practically water insoluble while the 
remaining cyclohexanol derivatives (Fig . 2) were slightly water sol-
uble. Accordingly, the ethynyl derivatives were dissolved in 50 per 
cent polyethylene glycol (PEG) 400, and aqueous solutions of the 
remaining cyclohexanol derivatives, as well as the cyclohexylamine 
hydrochloride salts were used throughout the investigation. 
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C. DETERMINATION OF COMPOUND SOLUBILITY 
The water solubilities of the non-ethynyl derivatives of cyclo -
hexanol and the cyclohexylamine hydrochloride salts were determined 
at room temperature (22°C) according to the following procedure: 
10-30 mg portions of the compound were placed in vials. All 
weight determinations were carried out on the Mettler 1 analytical 
balance. The solvent volume was determined by adding deionized 
water dropwise from a 0. 25 ml tuberculin syringe. After each addi-
tion, the vial was thoroughly agitated on the Vortex2 mixer for one 
minute. The vial was then held to a bright lamp, and solution was 
1. Mettler Instrument Corp. Hightstown, N . J . 
2. Scientific Industries, Inc. Springfield , Mass. 
Cl 
Fig.I Cyclohexylamine h:ydrochloride derivatives. 
H+ 
' CH3-~ H 
Cl - CH 3 
Cl 
trans-2- (.E.- Chlo rophenyl)-
N, N- dimethylcyclohexyl-
amine Hydrochloride 
trans-2- (.E.- Chlorophenyl)-
N-methylcyclohexylamine 
Hydrochloride 
(TH-25) 
Cl 
+ 
H- N- CH 
Cl - I 3 
CH3 
cis-2-(E.-Chlorophenyl)-
N, N-dimethylcyclohexyl-
amine Hydrochloride 
(TH-27) 
(TH-26) 
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Fig. 2 Cyclohexanol derivatives. 
OH 
trans-2-£-Tolyl-cis-4-
hydroxy-trans-5-hydroxy-
cyclohexanol (CH- 21 ) 
CH3 H 
trans-2-~-Tolyl -trans ­
l, 5-cyclohexanediol 
(CH-20) 
OH 
trans-2-~-Tolyl-cis-l, 4, -
cyclohexanediol (CH -14) 
l-Ethynyl-trans-2-~-tolyl­
cyclohexanol (AH-64) 
l-Ethynyl - cis - 2-~-tolyl­
cyclohexanol (AH - 6 5) 
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Table I Physical state and water solubility of the non-ethynyl cyclohex-
anol derivatives and of the cyclohexylamine hydrochloride salts . 
COMPOUND 
trans-2-,£-tolyl- cis - 4-
hydroxy-trans-5-hydroxy-
cyclohexanol (CH - 21) 
trans-2-,£-tolyl- cis -1, 4-
cyclohexanediol (CH -14) 
trans-2-,£-tolyl-trans~l, 5-
cyclohexanediol (CH - 2 0) 
trans -2- (E.- chlorophenyl}-
N, N-dimethylcyclohexyl-
amine HCL (TH-25) 
trans-2-(.E.- chlo rophenyl}-
N-methylcyclohexylamine 
HCL (TH-26) 
cis-2-(,E.-chlorophenyl}-N, N-
dime thy lcyclohexylamine H CL 
(TH-27) 
a parts solute/ 100 parts sol vent 
PHYSICAL ST A TE 
solid 
solid 
solid 
solid 
solid 
solid 
WATER 
SOLUBILITYa 
at 22°C 
o. 58 
o. 39 
o. 9 5 
21.44 
29.43 
35. 50 
determined to be affected or not. The whole procedure was repeated 
three times for each compound and the ave rage of the determinations 
reported as the solubility. 
The water solubilities of the ethynyl derivatives of cyclohexanol 
were not determined as they were dissolved in a 50 per cent mixture 
of polyethylene glycol (PEG) 400 and deionized water prior to testing. 
D. ANIMALS USED 
Rats-Male albino rats of the Sprague-Dawley strain! were em-
ployed for all blood pressure and atrial experiments. 
Guinea pigs-Guinea pigs of either sex and of a heterogeneous 
group were used for all isolated heart experiments. 
E. EXPERIMENTAL PROCEDURES AND RESULTS 
The investigation was divided into four sections: 
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1. The effects of the cyclohexylamine hydrochloride salts and the 
non-ethynyl derivatives of cyclohexanol on the blood pressure 
of rats. 
2. The inotropic effects of all compounds on the isolated guinea 
pig heart. 
3. The inotropic and chronotropic effects of t:rans-2-~-tolyl­
trans-l, 5-cyclohexanediol (CH -20) and cis-2-(E_-chloro-
1. Charles River Breeding Farms, North Wilmington, Mass. 
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phenyl)-N, N-dimethylcyclohexylamine hydrochloride (TH-27) 
on isolated rat atria. 
4. The effects of trans-2-(:Q.-chlorophenyl) - N, N-dimethylcyclo -
hexylamine hydrochloride (TH-25) on the blood pressure of 
both the hexamethonium treated and reserpine pretreated rat. 
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1. Effects of the Non-Ethynyl Cyclohexanol Derivatives and the Cyclo-
hexylamine Hydrochloride Salts on the Blood Pressure of Rats. 
a. ) Experimental Procedures 
The effects of the compounds on the blood pressure of male albino 
rats (260g. , average weight) were recorded manometrically by direct 
cannulation of the right carotid artery. A fluid bridge of normal saline 
connected the cannula to a mercury manometer, and the blood pres sure 
responses were recorded on a slowly moving smoked kymograph. 
Rats were anesthetized with 1. 2g. /kg. of a freshly prepared 25 
per cent urethane solution administered intraperitoneally. Injections 
of the test compounds were made intravenously via a needle perma-
nently secured in the left femoral vein. To inhibit clotting, an intra-
venous injection of 0. 01 ml. of a 1:5000 solution of heparin sodium 
was given to each rat prior to cannulation. A similar concentration 
of heparin sodium was also injected into the cannula at this time. 
A minimum of twenty minutes was allowed to elapse prior to drug 
administration to enable the blood pressure to stabilize. Only one drug 
was injected for each experiment, and not more than six injections 
were made during one experiment. Following each injection, a twenty 
minute period was allotted to permit the return of the blood pres sure 
to a normal level. At the conclusion of each experiment a urine sample 
was withdrawn from the bladder and observed for hematuria. 
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Dosage was adjusted according to the results obtained, in order to 
determine the dose of a particular compound that would produce a drop 
in blood pressure of approximately 50 per cent. Dose and response 
were subjected to linear regression computations carried out by the 
IBM 1410 computer. The results were plotted and the dose producing 
a 50 per cent drop in blood pres sure calculated. 
The indices of activity used to compare the different compounds 
were as follows: 
(1) The per cent drop in blood pressure produced by the various 
compounds. 
(2) The duration of the hypotensive effect, i.e. time elapsed 
until the blood pressure returned to 95 per cent of the normal 
level. 
(3) The dose of the various compounds needed to produce a 50 per 
cent drop in blood pressure; i.e. ED50 (hypotensive). 
b. ) Results 
The results include the following: 
(1) Effects of the non-ethynyl cyclohexanol derivatives and the 
cyclohexylamine hydrochloride salts on the blood pressure of 
rats (Tables II to VII). 
(2) A comparison of the non-ethynyl derivatives of cyclohexanol 
and the cyclohexylamine hydrochloride salts on the blood 
pressure of rats . (Table VIII; Figs. 4 and 5). 
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Table II Effects of trans-2-o-tolyl-cis-4-hydroxy-trans-5-hydroxy -
- -
cyclohexanol (CH-21} on the blood pressure of rats. 
DOSE NUMBER OF MEAN% DROP DURATION OF 
(mg/kg} TRIALS IN BLOOD DROP 
PRESSURE (Mean and Range) 
± S.D . (Sec. ) 
1. 0 2 22 ± 5 185(150-220) 
2.0 2 33 ~ 5 195(170-220) 
3. 0 3 32 ~ 2 247(140-310) 
4.5 1 46 400 
6.0 3 29 ~ 5 73 (50-110) 
8.0 2 39 ~ 7 375(280-470) 
10. 0 2 73 ~ 11 230(190-270) 
12 .. 0 3 80 ~ 5 203(160-250) 
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Table III Effects of trans-2-Q-tolyl-cis - l , 4-cyclohexanedfol (CH -1 4) 
on the blood pressure of rats. 
DOSE NUMBER OF MEAN% DROP DURATION OF 
(mg/kg) TRIALS IN BLOOD DROP 
PRESSURE (Mean and Rang e ) 
t ' 
- S. D. (Sec. ) 
2.0 3 35 ~ 4 207(90 - 310) 
4.0 2 + 52 - 1 280(230 - 330) 
6.0 + 200(120 - 300) 3 41 - 5 
8.0 3 85 ~ 7 233(180 - 320) 
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Table IV Effects of trans-2-£-tolyl-trans- l, 5-cyclohexanediol (CH-20) 
on the blood pressure of rats. 
DOSE NUMBER OF MEAN %:DROP DURATION OF 
(mg/kg) TRIALS IN BLOOD DROP 
PRESSURE (Mean and Range) 
+ (Sec. ) - S. D. 
2.0 3 42 ± 8 1 73(140 - 220) 
4.0 3 53 ~ 14 155(80-2 30) 
6.0 2 47: 22 50(30- 70) 
8.0 4 63 ± 28 218(190-240) 
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Table V Effects of trans-2-(E-chlorophenyl)-N, N-dimethylcyclohexyl -
DOSE 
(mg/kg) 
4.0 
6.0 
8.0 
amine HCL (TH-25) on the blood pressure of rats. 
NUMBER OF 
TRIALS 
5 
5 
4 
MEAN% RISE 
IN BLOOD 
PRESSURE 
± S.D. 
20 ~ 9 
28 ~ 10 
23 ~ 4 
DURATION OF 
RISE 
(Mean and Range) 
(Sec. ) 
44(30-60) 
74(40-100) 
108(90-130) 
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Table VI Effects of trans-2- (2-chlorophenyl) -N-methylcyclohexyl-
amine J-ICL (TH-26) on the blood pressure of rats. 
DOSE NUMBER OF MEAN% DROP DURATION OF 
(mg/kg) TRIALS IN BLOOD DROP 
PRESSURE (Mean and Range) 
+ 
- S. D. (Sec. ) 
2.0 2 5 ~ 0 25(20-30) 
4.0 3 13 ~ 3 40(20-50) 
6.0 3 25 ~ 5 74(40-90) 
8.0 3 39 ~ 17 237(130-420) 
10. 0 3 39 ~ 14 123(40-200) 
12.0 3 42 "i: 9 113(50-230) 
14.0 2 + 32 - 4 155(150-160) 
18.0 1 38 130 
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Table VII Effects of cis-2-(£.-chlorophenyl)-N, N-dimethylcyclohexyl -
amine HCL (TH-27) on the blood pressure of rats. 
DOSE NUMBER OF MEAN% DROP DURATION OF 
(mg/kg) TRIALS IN BLOOD DROP 
PRESSURE (Mean and Range) 
+ (Sec. ) - S. D. 
2.0 2 20 ~ 8 25(20-30) 
+ 
4.0 3 28 - 5 33(30-40) 
+ 90(60-120) 6.0 3 46 - 4 
8.0 2 57 ~ 4 130(110-150) 
10.0 3 + 43 - 2 97 (70-110) 
+ 
14.0 3 42 - 4 13 7(70-200) 
Tracings from kymograph records. 
f-16 0 Sec. 
f 4. 0 mg/Kg 
(TH-25) 
l..l 
...... 
~ ... ,. ,...,..._...~- ...... 
1--160 Sec. 
'f' 4. 0 mg/Kg 
(TH-26) 
--
·~.,. 
I I 60 Sec. 
t 4. 0 mg/Kg 
(TH-27 ) 
Fig. 3 Rat blood pressure response to each of the cyclohexylamine 
hydrochloride salts (4. 0 mg. /Kg.). 
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Fig. 4 A comparison of the hypotensive effects produced by the cyclo-
hexanol derivatives. 
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Fig. 5 A comparison of the blood pres sure effects produced by the cyclo-
hexylamine hydrochloride derivatives. 
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Table VIII A comparison of the ED50 (hypotensive) of the non-ethynyl 
cyclohexanol derivatives and the cyclohexylamine derivatives 
a 
on the blood pres sure of rats 
COMPOUND 
trans -2-£_-tolyl-cis-4-hydroxy-
trans-5-hydroxycyclohexanol (CH-21) 
trans-2-£_-tolyl- cis-1, 4-cyclohex-
anediol (CH-14) 
trans-2-£_-tolyl-trans- l, 5-cyclohexanediol 
(CH-20) 
trans-2- (e.-chlorophenyl)-N-methyl-
cyclohexylamine HCL (TH-26) 
cis-2-(E.-chlorophenyl)-N, N-dimethyl-
cyclohexylamine HCL (TH-2 7) 
a See Figs. 4 and 5. 
TOTAL 
TRIALS 
18 
11 
12 
20 
16 
CALCULATED 
b ED50 
(mg/kg) 
5.30 
3.95 
4.04 
26.30 
12.94 
b derived from the regression line formula which was obtained from the 
analysis of results on the IBM 1410 Computer . 
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2. Effects of the Cyclohexanol Derivatives and the Cyclohexylamine 
Hydrochloride Salts on the Contractility of the Isolated Guinea 
Pig Heart. 
a.) Experimental Procedures 
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Guinea pigs of either sex weighing between 465 and 989 g. were 
sacrificed by cervical dislocation. Following removal of the sternum 
and retraction of the ribs, the heart was prepared in the following 
manner: 
1. Clamping and cutting distally, the descending aorta in the area 
of the diaphragm. 
2. Severing the intercostal, innominate, and left subclavian 
arteries, thus freeing the aorta. 
3. Severing the superior and inferior venae cava.e. 
After severing the trachea, the heart was rapidly removed with 
the lungs attached and transferred to a dish of oxygenated perfusion 
solution at room temperature. A glass cannula was inserted into the 
aorta and tied firmly in place so that its 1 tip was just proximal to the 
innominate artery and distal to the coronary ostia. Several ml of warm 
oxygenated perfusion solution combined with 0. 1 ml of a 1 : 000 solution 
of heparin sodium were gently forced into the coronary arteries to re -
move residual blood and minimize the possibility of the formation of 
small clots within these vessels. 
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The cannulated heart was then transferred to an Anderson-
Craver heart perfusion apparatus 1 , modified by maintaining a constant 
fluid level in the perfusion well. The siphoned fluid was collected with 
the aid of a pump and returned to the perfusion fluid reservoir, through 
a glass tube placed in the upper end of the well, which projects above 
the warming chamber. 
Following stabilization of the preparation under a perfusion head 
pres sure of 54 cm of water and at a constant temperature of 3 7. s0 c 
maintained by a water bath, all extraneous tis sue including the peri-
cardium was dissected free. A stainless steel hook was inserted into 
the ventricular musculature at the heart's apex and the lower portion 
of the apparatus secured in place. By means of a cotton thread run-
ning from the hook, through a pulley system to a recording lever, the 
cardiac contractions were recorded on a slowly moving smoked kymo-
graph. 
The perfusion solution used in all experiments was that recom-
mended by Cheno~eth and Koelle (1946) slightly modified by Smookler 
and DeFeo (1962). 
1. Metro Industries, Long Island City, N. Y . 
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The composition of the perfusion solution expressed in grams per 
liter and in millimoles per liter is as follows: 
ill mM/l 
NaCl 7.0 119. 8 
KCl 0.42 5. 63 
CaC12 0.24 2. 16 
MgS04 0.52 2. 11 
dextrose 1. 80 10. 00 
NaHC03 2. 1 25.00 
Three liters of stock solution containing 350 g. sodium chloride, 
l 'i 
21. 0 g. potassium chloride, .16. 0 g. calcium chloride and 26. 0 g . 
magnesium sulfate 1 were prepared and stored at room temperature. 
The final perfusion fluid was prepared for each experiment by taking 
120 ml. of stock solution, 3. 6 g. dextrose and 4. 2 g. of sodium bi-
carbonate and sufficient deionized water to make two liters of solution . 
This was immediately oxygenated with a mixture of 95 per cent oxygen 
and 5 per cent carbon dioxide. The pH of the final solution was 7. 9. 
Throughout each experiment, the effluent perfusate was not recycled, 
but was collected and discarded. 
After recording normal cardiac contractions, injections (tri als) 
1. The heptahydrate salt was used throughout this work. 
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were made via an injection spiral connected to the perfusion canal , and 
displaced (washed) with a volume of perfusate equal to that held by the 
spiral (1. 5 ml.). At least one subsequent wash followed recovery to 
assure complete introduction of the entire dose of test material. Only 
one compound was tested in each experiment, and not more than five 
injections were made during one experiment. Succeeding doses were 
administered not less than ten minutes from the t ime of recovery of 
the previous dose. In the case of the ethynyl derivatives of cyclo-
hexanol the procedure was modified to include the injection of 50 per 
cent polyethylene glycol (PEG) 400 as a control at the beginning and end 
of each experiment. The volume of the control equaled that of the drug 
and solvent combined for a particular dose. 
A depression of 95 per cent or more from the normal was con-
sidered to be cardiac arrest, and recovery was allowed to take place 
spontaneously. Once again dose and response were subjected to linear 
regression computations carried out by the IBM 1410 computer. The 
results were plotted and the dose capable of producing a 95 per cent 
negative inotropic response calculated. 
In two experiments involving trans - 2 - (.E_- chlorophenyl)-N, N-
dimethylcyclohexylamine hydrochloride (TH - 25) and trans - 2 -
(.£-chlorophenyl)-N-methylcyclohexylamine hydrochloride (TH-26) 
respectively, an indication of the per cent decrease in coronary flow 
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was obtained by recording the time required to collect 1. 0 ml. of 
effluent perfusate before and during the observed maximum cardiac 
depression. In another experiment, the antagonistic effect of the cal -
cium ion on the negative inotropic response to 1. 0 mg. of l-ethynyl-
cis-2-£-tolylcyclohexanol (AH-65) was recorded. During maximurri 
cardiac depression, various concentrations of calcium chloride were 
injected at intervals. 
The indices of activity used to compare the different compounds 
were as follows: 
(1) The incidence and duration of cardiac arrest at a particular 
dose. 
(2) The incidence and per cent of cardiac depression if no arrest 
occurred. 
(3) The time of recovery to 50 per cent of the normal cardiac 
contraction. 
b. ) Results 
The results include the following: 
(1) Effects of th~ cyclohexanol derivatives and the cyclohexylamine 
hydrochloride salts on the isolated guinea pig heart (Tables 
IX to XV). 
(2) A comparison of the cyclohexanol derivatives and the cyclohexyl-
amine hydrochloride salts on the isolated guinea pig heart 
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(Table XVI; Fig. 11). 
(3) The antagonistic effect of various calcium ion concentrations 
on the negative inotropic response to 1. 0 mg. of l-ethynyl -
cis-2-~-tolylcyclohexanol (AH - 65) (Fig. 7 ). 
(4) Three trials using 1. 0 mg, of trans - 2 -~- to lyl-cis-4-hydroxy­
trans-5-hydroxycyclohexanol produced a mean decrease in 
amplitude of cardiac contraction of onl y 10 per cent with a 
standard deviation of 6. Due to insufficient compound, the 
higher do sage levels could not be investigated. 
(5) Trials using 0. 5 mg of trans-2-(p_-chlorophenyl)-N , N-
dimethylcyclohexylamine hydrochloride (TH - 25) and trans -
2-(p_-chlorophenyl}-N-methylcyclohexylamine hydrochloride 
(TH-26) showed a mean per cent increase in the time requir -
ed to collect 1. 0 ml of effluent perfusate of 100 per cent and 
88 per cent respectively. The mean control time to collect 
1. 0 ml of effluent perfusate was 8 seconds for both compounds. 
The former compound showed an increase in mean time of 8 
seconds and the latter compound an increase of 7 seconds. 
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Table IX Effects of trans-2-~-tolyl-cis-l, 4-cyclohexanediol (CH-14) on the isolated guinea pig heart. 
DOSE o/oP. E.G. a CARDIAC ARREST DURATION MEAN% TIME OF 50% 
(mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION .. RETURN 
+ (ml) (Mean and 
- S. D. (Mean and 
range} (if no arrest) range) 
(Sec. ) (Sec. ) 
0/0.14 0/2 + 0.5 - 23 - 11 
1. 0 0/0.29 0/5 - 33-: 13 
2.0 0/0.40 0/3 - + 57 - 5 9(6-10 ) 
3.0 0/0.60 0/3 - 61 : 9 8(2-12) 
4.0 0/0.80 1/2 12 81 87(40-134) 
a per cent polyethylene glycol 
U1 
...... 
Table X Effects of trans-2-~-tolyl-trans-l, 5-cyclohexanediol (CH-20) on the isolated guinea pig heart. 
DOSE o/oP. E.G. 
a 
CARDIAC ARREST DURATION MEAN% TIME OF 50% 
(mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION RETURN 
(ml) (Mean and + (Mean and 
- S. D. 
range) (if no arrest ) range ) 
(Sec. ) (Sec. ) 
1. 0 0/0.10 0/2 
-
+ 10 - 7 
3.0 0/0.30 1/3 11 + 93 - 1 21(14-27) 
4.0 0/0.40 3/3 15(3-28) 
-
24(9-38) 
a per cent polyethylene glycol 
Vl 
N 
Table XI Effects of l-ethynyl-trans-2-£-tolylcyclohexanol (AH-64) on the isolated guinea pig heart. 
DOSE 
{mg) 
0.5 
I. 0 
2.0 
3.0 
a %P. E.G. 
DOSE VOL. 
(ml) 
50/0.05 
50/0. 10 
50/0.40 
50/0.60 
CARDIAC ARREST 
ARRESTS/TRIALS 
0/3 
0/3 
0/3 
2/2 
a per cent polyethylene glycol 
I. R. - incomplete recovery 
N. R. - no recovery 
DURATION 
OF ARREST 
(Mean and 
range) 
(Sec. ) 
MEAN% 
DEPRESSION 
+ 
- S. D. 
(if no arrest) 
58 ~ 22 
66 ~ 6 
+ 92 - 1 
TIME OF 50% 
RETURN 
(Mean and 
range) 
(Sec. ) 
I. R. 
316(258-382) 
796(366-1676) 
N.R. 
Ul 
(.;) 
Tracing from kymograph record. 
t 1 Min. 
3. 0 mg (AH-64) 
Fig. 6 The cardio-toxic effect of l-ethynyl-trans -2-£-tolylcyclohexanol 
(3. 0 mg.) on the isolated guinea pig heart. 
'"<t~.+'~:::.Wr-~"'-----:~-Jl :~ 1l~ttr.\5~'&ifift§··'"-c,,~ili.,.,_ 
90 Min. 
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Table XII Effects of l-ethynyl-cis-2-£-tolylcyclohexanol (AH-65) on the isolated guinea pig heart. 
DOSE o/oP. E.G. 
a 
CARDIAC ARREST DURATION MEAN% TIME OF 50o/o 
{mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION RETURN 
(ml) (Mean and + (Mean and ;.; S. D. 
range) (if no arrest) range) 
(Sec. ) (Sec. ) 
0.5 50/0. 10 0/3 
-
68 ~ 9 398(3 36-452) 
1. 0 50/0.20 3/4 208(181-234) 89 329(277-385 ) 
2.0 50/0.40 3/3 586(419-886 ) 
-
1280 (980-1658) 
a 
per cent polyethylene glycol 
U"1 
U"1 
.. ( 
Tracing from k~ograph record. 
I 
'f' 1 Min. 
1. 0 mg (AH-65) 
3 Min. 
1' 8. O mg CaCl2 
4 Min. 
t 16 mg CaC12 
Fig. 7 The effect of calcium chloride (8. 0 mg. and 16. 0 mg. ) on the 
isolated guinea pig heart following 1. 0 mg . of 1- ethynyl-cis-2-
£- tol ycyclohexanol. 
~'""""·£v~~ .... ~ 
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Table XIII Effect of trans-2-(E_-chlorophenyl)-N, N-dimethylcyclohexylamine HCL (TH-25) on the 
isolated guinea pig heart. 
DOSE o/oP. E.G. 
a CARDIAC ARREST DURATION MEAN% TIME OF 50% 
(mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION RETURN 
(ml) {Mean and + {Mean and 
- S. D. 
range) {if no arrest) range) 
(Sec. ) (Sec. ) 
0.25 0/0.025 0/3 - 77 "±: 15 353(183-600) 
o. 5 0/0 . 05 1/3 46 + 87 - 5 202(68-335 ) 
1. 0 0/0.10 2/3 314(248-380) 92 870(645-1190 ) 
a per cent polyethylene glycol 
\}l 
.._] 
Tracing from kymograph record. 
I I t 1 11in. 
1. 0 mg (TH-25) 
4 11in. 10 11in. 
Fig. 8 The effect of trans-2-(E-chlorophenyl)-N, N-dimethylcyclohexyl-
amine hydrochloride (1. 0 mg~ ) on the isolated guinea pig heart. 
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Table XIV Effect of trans-2-(E_-chlorophenyl)-N-methylcyclohexylamine HCL (TH-26) on the isolated 
guinea pig heart. 
DOSE o/oP. E.G. a CARDIAC ARREST DURATION MEAN% TIME OF 50% 
{mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION RETURN 
(ml) (Mean and + (Mean and - S. D. 
range) (if no arrest) range) 
(Sec. ) (Sec. ) 
0.5 0/0.50 0/3 
-
88 ~ 1 556(448-638) 
1. 0 0/0. 10 2/3 140(103-176) 78 868(554-1049) 
2.0 0/0.20 3/3 93(42-142) 
-
493(372-612) 
a 
per cent polyethylene glycol 
U1 
'° 
Tracing from kymograph record. 
f I Min. 
2. 0 mg (TH-26) 
10 Min. 
Fig. 9 The effe c t of trans-2-(E.-chlorophenyl)-N-Methylcyclohexylamine 
hydrochloride (2. 0 mg.) on the isolated guinea p i g heart. 
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Table XV Effect of cis-2-(E_-chlorophenyl)-N, N-dimethylcyclohexylamine HCL (TH-27) on the isolated 
guinea pig heart. 
DOSE o/oP. E.G. a CARDIAC ARREST DURATION MEAN% TIME OF 50% 
(mg) DOSE VOL. ARRESTS/TRIALS OF ARREST DEPRESSION RETURN 
(ml) (Mean and ± S.D. (Mean and 
range) (if no arrest) range) 
(Sec, ) (Sec.) 
0.25 0/0.025 0/3 
-
76 ~ 8 5 58 ( 509-644) 
0.5 0/0.05 0/4 
-
82 ~ 12 411 (126-628) 
1. 0 0/0. 10 3/3 470 (308-636) 
-
1205(556- 1 970 ) 
a 
per cent polyethylene glycol 
0--
,_. 
Tracing from kymograph record. 
I 
A\ l Min. 
I' 1. 0 mg (TH - 2 7) 
5 Min. 
Fig. 10 The effect of cis-2-(E.-chlorophenyl)-N, N-dimethylcyclohexylamine 
hydrochloride (1. 0 mg.) on the isolated guinea pig heart. 
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Fig. 11 A comparison of the cardio-inhibitory effects produced by the 
derivatives of cyclohexanol and cyclohexylamine hydrochloride, 
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Table XVI A comparison of the ED95 (cardio-inhibitory) of the cyclo-
hexanol and cyclohexylamine derivatives on the isolated 
guinea pig heart~ 
COMPOUND 
trans-2-_£-tolyl-cis- l, 4-cyclohexanediol 
(CH-14) 
trans-2-_£-tolyl-trans- l, 5-cyclohexan-
ediol {CH-20) 
1- ethynyl-trans-2-_£-tolylcyclohexanol 
(AH-64) 
l-ethynyl-cis-2-_£-tolylcyclohexanol 
(AH-65) 
trans-2-(E_- chlorophenyl)-N, N-dimethyl-
cyclohexylamine HCL (TH-25) 
trans-2- (E_-chlorophenyl)-N-methyl-
cyclohexylamine HCL (TH-26) 
cis-2-(.E_-chlorophenyl)-N, N-dimethyl-
cyclohexylamine HCL (TH-27) 
a See Fig. 11. 
TOTAL 
TRIALS 
15 
8 
11 
10 
9 
8 
10 
CALCULATED ~, 
ED95b 
(mg) 
6. 80 
3. 38 
2. 52 
1. 33 
0.78 
1. 19 
0.85 
b derived from the regression line formula which was obtained from the 
analysis of results on the IBM 1410 Computer. 
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3. Effects of trans-2-o-Tolyl - trans-l, 5-cyclohexanediol (CH - 20) and 
cis-2-(p-Chlorophenyl)-N, N-dimethylcyclohexylamine Hydrochloride 
(TH-27) on the Contractility of the Isolated Rat Atria. 
a . ) Experimental Procedures 
Male albino rats weighing 275-350 g. were killed by cervical 
dislocation and the hearts rapidly excised. The atria were freed of 
ventricular muscle, fat and connective tissu e and suspended vertically 
in 8 ml of modified Chenoweth-Koelle solution aerated with a mixture 
of 95 per cent oxygen and 5 per cent carbon dioxide. The bathing 
solution was of the same composition and pH, as that used in the isola-
0 
ted guinea pig heart experiments and maintained at 29 C as suggested by 
Burn and Vane (1949). 
The amplitude of isotonic contractions and the rate of spontaneous 
beat were recorded under a resting tension of approximately O. 75 g. on 
a smoked kymograph. Following suspension in the bath, the tissues were 
allowed to stabilize for twenty to thirty minutes before use. The addi -
tion of drugs directly into the 8. 0 ml bath did not alter its 1 volume by 
more than 4 per cent. 
Apart from the ethynyl derivatives, t r ans - 2 -~-tolyl- trans - l, 5 -
cyclohexanediol (CH-20) seemed to give the most consistent effect on 
the isolated guinea pig heart. For this reason, i t was selected for 
testing on the isolated rat atria. Likewise, cis - 2 - (E_-chlorophenyl) -
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N, N-dimethylcyclohexylamine {TH-27) hydrochloride was chosen as the 
representative of the cyclohexylamine derivatives to be tested on the 
isolated rat atria. A 4. 0 per cent solution of calcium chloride was used 
to determine the possible interactions with the above compounds. All 
substances were allowed to act on the suspended tis sue for at least 
three minutes. A minimum of three washes over a period of five min-
utes were performed between trials, and the tissue allowed an additional 
five minute recovery period before proceeding to the next trial. Both 
compounds produced an effect lasting indefinitely when not washed. 
The indices of activity used to evaluate the two compounds were: 
1) The per cent change in amplitude of contraction. 
2) The change in the beating rate of the preparation. 
b.) Results 
The results include the following: 
(1) The effect of trans-2-£-tolyl-trans-l, 5-cyclohexanediol (CH-20) 
on the isolated rat atria {Fig. 12). 
(a.) 4. 0 mg of calcium chloride produced an increase in ampli-
tude of contraction of approximately 70 per cent at the end of three min-
utes reaching a maximum of approximately 300 per cent within thirty 
seconds. Over the three minute period the rate increased steadily from 
160 to 180 beats per minute. 
(b.) O. 6 mg of trans-2-£-tolyl-trans- l, 5-cyclohexanediol 
+300 
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0---0 4. o mg CaC12 
b.-----6 O. 6 mg {CH-20) foUowed by 4. 0 mg CaC12 
~ 4. 0 mg CaC12 followed by O. 6 mg (CH-20) 
0--0 4. 0 mg CaC12 and O. 6 mg (CH-20) 
0--0 
~ {'It, ~ ['., ['., 
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cac12 
~ 
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,t'j ~ 
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-100 t-~~~~.--~~~ ....... ~~~~--~~~------~~~---~~----------------........ --------~~~~ 
60 120 180 240 
Seconds 
300 360 420 480 
Fig. 12 The effects of trans-2-£-tolyl-trans-l, 5-cyclohexanediol (0. 6 mg.) and 
calcium chloride (4. 0 mg. ) on isolated rat atria. 
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(CH-20) reduced the amplitude of contraction by approximately 70 per 
cent within thirty seconds, with no apparent change in the rate. At the 
end of three minutes, a dose of 4. 0 mg of calcium chloride restored 
the amplitude to control level. No change in the rate of contraction 
was observed over the tissue exposure time of nine minutes. 
(c.) 4. 0 mg of calcium chloride again produced an increase 
of approximately 300 per cent within one minute. At this time, 0. 6 mg 
of trans-2-_£-tolyl-trans- l, 5-cyclohexanediol (CH-20) was given. The 
increase in amplitude was approximately 100 per cent above the control 
at the end of three minutes. Rate increased steadily from 120 to 140 
beats per minute over the total exposure time of four minutes. 
: (.d.) 'Since it has been suggested that the action of many cardio-
plegic agents might possibly be the result of the formation of a calcium 
chelate, O. 6 mg of trans-2-_£-tolyl-trans-l, 5-cyclohexanediol (CH-20) 
and 4. 0 mg of calcium chloride were combined in a syringe for fifteen 
minutes prior to administration. When the drug combination was instil-
led into the bath, amplitude of contraction reached a maximum increase 
of approximately 200 per cent within one minute. After three minutes 
the amplitude increase leveled off at 50 per cent. The rate at the end 
of one and three minutes respectively was 150 and 160 beats per minute. 
(2) The effect of cis-2-(E-chlorophenyl} -N, N-dimethy~cyclohexyl­
amine hydrochloride (TH-27) on the isolated rat atria (Fig. 13). 
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Fig. 13 The effects of cis -2-(E_-chlorophenyl )-N, N-dimethylcyclohexylamine hydro-
chloride (0. 6 mg. and 1. 2 mg. ) and calcium chloride (4. 0 mg. and 8. 0 mg. ) 
on isolated rat atria. 
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(a.) 4. 0 mg of calciwn chloride produced an increase in ampli-
tude of contraction of approximately 300 per cent within one minute 
followed by a gradual return to the control level within three minutes. 
The rate of contraction increased steadily from 140 to 200 beats per 
minute over the three minute period. 
(b.) O. 6 mg of cis-2-(E.-chlorophenyl) - N, N-dimethylcyclo-
hexylamine hydrochloride {TH-27) produced an amplitude increase of 
approximately 150 per cent within one minute with a gradual reduction 
to 50 per cent above the control level at the end of five minutes. At 
this time, a second dose of O. 6 mg of the compound restored the ampli -
tude to approximately 100 per cent above the control level within one 
minute. The amplitude gradually decreased to 50 per cent below the 
control level twelve minutes after the first dose of the compound was 
added. 4. 0 mg of calciwn chloride given at this time restored the 
amplitude to the control level at the end of the fifteenth minute. During 
the first five minutes, the rate decreased from 120 to 70 beats per 
minute. After the second dose of the compound was given the rate was 
further reduced to 40 beats per minute. The calciwn chloride increas -
ed the rate from 40 to 42 beats per minute during the final three min-
utes of tissue exposure. 
(c.) 1. 2 mg of cis-2-(E.-chlorophenyl)-N, N-dimethylcyclo -
hexylamine hydrochloride {TH-27) produced an increase in amplitude 
r 
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of contraction of approximately 75 per cent within thirty seconds, 
followed by a rapid return to control level at the end of one minute. 
During the next five minutes the amplitude gradually dropped below 
the control level by approximately 90 per cent. At the six minute 
mark, 8. 0 mg of calcium chloride restored the amplitude to approx-
imately 30 per cent below the control level. Within the first minute 
of tissue exposure, the rate decreased fr om 100 to 90 beats per min-
ute. During the next five minutes the rate fell to 45 beats per minute. 
The calcium chloride failed to improve the rate as it continued to 
decr,ease and at the twelve minute mark was 35 beats per minute. 
(d.) 1. 2 mg of cis-2-(E.-chlorophenyl)-N, N - dimethylcyclo-
hexylamine hydrochloride (TH-2 7) combined with 8. 0 mg of calcium 
chloride in a syringe for fifteen minutes prior to administration , 
produced an increase in amplitude of approximately 60 per cent by the 
end of the first two minutes and fifty seconds. Within the next ten 
seconds, the amplitude fell to approximately 30 per cent below the con-
trol level. The amplitude reached control level within the next two 
minutes, but gradually fell to approximately 60 per cent below the con-
trol at the end of the tissue exposure time of 15 minutes. The rate of 
contraction increased from 85 to 95 beats per minute wit.h.in the first 
ninety seconds. It then declined steadily to 55 beats per minute after 
three minutes and eventually fell to 38 beats per minute at the end of 
the fifteen minute period. 
.. _ 
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4. Effects of trans-2-(p- Chlorophenyl}-N, N-dimethylcyclohexylamine 
Hyd;rochloride (TH-25) on the Blood Pressure ~Both the Hexa-
methonium Treated and Reserpine Pretreated Rat. 
a. ) Experimental Procedures 
The experimental procedures were basically the same as those 
previously described; (part 1 of experimental procedures and results). 
Male albino rats weighing 194-232 g. were anesthetized with 1. 2 g/kg 
of freshly prepared 25 per cent urethane administe re d intraperitoneally. 
Following cannulation of the right common carotid, the blood pressure 
was recorded manometrically on a smoked kymograph at a moderate 
rate. All injections were made via a needle permanently secured in 
the left femoral vein. The left common carotid was isolated and a 
loose ligature passed beneath it. When clamping the left common car-
otid, the ligature was lifted and a taped bull-dog clamp secured proxi -
mal to the bifurcation. Care was taken to avoid unnecessary stretch-
ing of the artery and manipulation of the cervical sympathetic and vagus 
nerves. 
Intravenous hexamethonium (20 mg/kg) was employed for its' 
competitive blocking action at the autonomic ganglia. Halpern et al. 
(1954) showed that this compound markedly depressed the vasopres sor 
reflexes of carotid sinus origin . 
The preparation was allowed to stabilize for twenty minutes and 
. . . 
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then the following tests were utilized at five minute intervals*: 
1. } occlusion of the left common carotid for ten seconds. 
2.} epinephrine (0. 06 ml of 1: 100, 000 solution} 
3, } trans- 2- (E.- chlo rophenyl}- N, N - dimethylcyclohexylamine 
hydrochloride (TH-25} (4. 0 mg /kg}. 
4.} hexamethonium (20 mg/kg} (*ten minute pause} 
5.} repeat test 1.} 
6.} repeat test 2. } 
7. } repeat test 3. } 
The per cent change in blood pressure produced by trans-2-(E_-chloro-
phenyl}-N, N-dimethylcyclohexylamine (TH-25} before and after the 
administration of hexamethonium was the index of activity studied. 
The e££ect of reserpine pretreatment on the presser response to 
trans-2-(E.-chlorophenyl}-N, N-dimethylcyclohexylamine hydrochloride 
(TH-25} was also studied. 1. 0 mg/kg of reserpine was administered 
intraperitoneally on three successive days prior to the experiment. 
Once again, the preparation was allowed twenty minutes in which 
to stabilize and then the following tests were utilized at five minute 
. 1 * interva s : 
1.} occlusion of the left common carotid for ten seconds. 
2.} trans-2-(E.-chlorophenyl}-N, N-dimethylcyclohexylamine 
hydrochloride (TH-25} (4. 0 mg/kg}. 
3.) epinephrine (0. 04 ml of 1: 100, 000 solution) 
4.) dibenamine (15. 0 mg/kg.) (>!\en minute pause} 
5. ) repeat test 2. ) 
6. ) repeat test 3. ) 
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The per cent change in blood pressure produced by trans-2-(E_-chloro-
phenyl}-N, N-dimethylcyclohexylamine hydrochloride (TH-25) before 
and after the administration of dibenamine was the index of activity 
studied. 
b.) Results 
The results include the following: 
(1) The , effects of trans-2-(E_-chlorophenyl} - N, N - dimethylcyclo -
hexylamine hydrochloride (TH-25) on the blood pressure 
of the hexamethonium treated rat (Figs. 14 and 15). 
(a.) Occlusion of the left common carotid for ten seconds pro-
duced a transient increase in blood pres sure of approximately 22 per 
cent. 
(b.) Epinephrine (0. 06 ml of 1: 100, 000 solution) produced an 
increase in blood pressure of approximately 85 per cent with the 
response lasting sixty seconds. 
(c.) trans-2-(E_-Chlorophenyl)-N, N-dimethylcyclohexylamine 
hydrochloride (TH-25) (4. 0 mg/Kg) produced an increase in blood 
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Tracings from kymograph records. 
160 
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80 
60 
mm. 
Hg. 
I I 
60 Sec. 60 Sec. 30 Sec. 
Occl. 1' L. Car. 1' epi. (0. 06 ml/ 1: 100, 000 sol. ) 1' (TH-25) (4. 0 mg/kg) 
Fig. 14 The effect of trans-2-(:e.-chlorophenyl}-N, N-dimethylcyclohexyl -
amine hydrochloride (4. 0 mg. /Kg.) on rat blood pressure, prior 
to hexamethonium (20 mg. /Kg.) 
120 
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80 
60 
40 
mm. 
~ 
10 Sec. 60 Sec. 30 Sec. 
H g. 
Occl:. tL. Car. 1'epi. (0. 06ml/l:100, 000 sol.) 1'(TH-25) (4. 0 mg / k g) 
Fig. 15 The effect of trans-2-(E,-chlorophenyl) - N , N-dimethylcyclohex ylamine 
hydrochloride (4. 0 mg. /Kg.) on rat blood pressure, following hex a-
methonium (20 mg.' /Kg. ). 
pressure of approximately 60 per cent with the response lasting sixty 
seconds. 
(d.) Ten minutes after the slow intravenous injection of 
hexamethonium (20 mg/Kg), occlusion of the left common carotid for 
ten seconds failed to elicit the above mentioned presser response. 
(e. ) A second injection of epinephrine (0. 06 ml of 1: 100, 000 
solution) produced an increase in blood p ressure of approximately 
60 per cent. Again, the response lasted sixty· seconds. 
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(£.)A second injection of trans-2-(£_-chlorophenyl)-N, N-
dimethylcyclohexylamine hydrochloride (TH - 25) (4, 0 mg/Kg) produced 
an increase in blood pressure of approximately 42 per cent with the 
response lasting thirty seconds. 
(2) The effects of trans-2-(£_-chlorophenyl)-N, N - dimethylcyclo -
hexylamine hydrochloride (TH-25) on the blood pressure of 
the reserpine pretreated rat (Figs. 16 and 17). 
(a~) Occlusion of the left common carotid for ten seconds 
failed to produce any alteration in the blood pres sure. 
(b. ) trans-2-(£_-Chlorophenyl)-N, N-dimethylcyclohexylamine 
hydrochloride (TH-25) (4. 0 mg/Kg) produced a presser response of 
approximately 42 per cent, with a duration of ninety seconds. 
(c.) Epinephrine (0. 04 ml of 1: 100, 000 solution) produced an 
increase in blood pressure of approximately 32 per cent with the . -
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'I;'racings from kyniograph records. 
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Fig. 16 The effect of trans-2-(E.-chlorophenyl)-N, N-dimethylcyclohexylamine 
hydrochloride (4. 0 mg. /Kg.) on the blood pres sure of the reserpine 
pretreated rat prior to dibenamine (15 mg. /Kg.). 
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sol. ) 
Fig. 17 The effect of trans-2-(£.-chlorophenyl)-N, N-dimethylcyclohexylamine 
hydrochloride (4. 0 mg. /Kg.) on the blood pressure of the reserpine 
pretreated rat following dibenamine ( 15 mg. /Kg. ). 
(TH-25) 1' (4. 0 mg /kg) 
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response lasting fifty seconds. 
{d.) Ten minutes after the slow intravenous injection of 
dibenamine (15 mg/Kg), a second injection of trans-2-(E_-chloro -
phenyl)-N, N-dimethylcyclohexylamine hydrochloride (TH-25) 
(4. 0 mg/Kg) produced only a 10 per cent increase in blood pressure. 
The response lasted forty seconds. 
(e.) A second injection of epinephrine (0. 04 ml of 1:100,000 
solution) produced only a 13 per cent increase in blood pressure with 
a duration of ten seconds . 
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IV. DISCUSSION 
A. BLOOD PRESSURE STUDIES 
In a preliminary investigation, Huitric et al. (1959) showed that 
2-(~-tolyl)-cyclohexanol, given intravenously produced a- rapid hypo-
tensive effect in the intact dog. Smookler and DeFeo (1962) reported 
that cyclohexanol and the cis and trans isomers of its liquid 2-aryl 
derivatives were capable of producing an immediate drop in the blood 
pres sure of the intact rat. Although no relationship between the hypo-
tensive response and the molecular spatial configuration could be made, 
substitution of a tolyl or chlorophenyl moiety in the nwnber two posi-
tion of the cyclohexanol ring increased the hypotensive activity consid-
erably. The unpublished results of Smith (1963) showed a similar 
hypotensive response in both the intact rat and cat to the intravenously 
administered isomers of tolyl and chlorophenyl cyclohexylamine. 
Once again, correlation between the response and spatial configuration 
was not evident. 
In the present investigation, only the non-ethynyl cyclohexanol 
derivatives and the cyclohexylamine hydrochloride salts could be tested 
for hypotensive activity. The solvent system employed for the ethynyl 
derivatives was found to possess an effect of its own on the blood pres-
sure of the intact rat. 
The results obtained with the non-ethynyl cyclohexanol derivatives 
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were typical of those previously obtained with other derivatives of 
cyclohexanol; all produced an immediate drop in blood pressure of short 
duration (Tables II to IV). The magnitude of the effect appeared to be 
somewhat proportional to the dose employed, while the duration of the 
effect did not. On the basis of the calculated ED50 (hypotensive) 
(Table VIII), little difference in activity exists between trans-2-o-
tolyl-cis-l, 4-cyclohexanediol and trans-2-£-tolyl-trans-l, 5-cyclo -
hexanediol. These compounds are the mono-hydroxyl substitution 
products of trans-2-~-tolylcyclohexanol. The calculated ED50 
(hypotensive) reported by Smookler (1961) for this compound in rats 
was O. 9 mg/kg. The calculated ED50 (hypotensive) for the above 
compounds was 3. 95 mg/kg and 4. 04 mg/kg respectively. trans-2-o-
Tolyl-cis-4-hydroxy-trans-5-hydroxy-cyclohexanol with an ED50 of 
5. 30 mg/kg represents the di-hydroxyl substitution product of trans-
2-£-tolylcyclohexanol. It seems likely therefore; that hydroxyl substi-
tution at either the four or the five position of trans-2-£-tolylcyclohex-
anol causes a 4 fold decrease of hypotensive activity, while hydroxyl 
substitution at both the four and five position causes an approximate 5 
fold decrease of hypotensive activity in the intact rat. This view is 
supported by Wilson and Gisvold ( 1956) who state that the activity and 
toxicity of the parent compound can be expected to decrease upon the 
introduction of hydroxyl groups into a chemical structure. 
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It was observed that these compounds produced periods of labored 
breathing or dyspnea, particularly with the higher doses used. Artifi~ 
cial respiration in some cases was employed to restore normal fun ction. 
The duration of respiratory depression appeared to parallel the tran-
sient hypotensive response of the blood pressure. Similar periods of 
dyspnea were observed by Smookler (1961) with the 2-aryl derivatives 
of cyclohexanol. Likewise, Smith (1963) repo rte d that when death occur-
red during the blood pressure studies of certain derivatives of cyclo-
hexylamine, respiratory arrest preceded cardiac arrest. 
The blood pressure response to the cyclohexylamine hydrochloride 
salts varied (Tables V to VII). trans-2-(E_-Chlorophenyl)-N-methyl -
cyclohexylamine hydrochloride and cis-2-(E,-chlorophenyl)-N, N-di-
methylcyclohexylamine hydrochloride each produced a depressor 
response. The duration and magnitude of the response appeared to be 
somewhat dose related. The hypotensive ED50 calculated for these two 1 compounds was 26. 30 mg/kg and 12. 94 mg/kg respectively {Table VIII). 
The difference in activity might be due to the cis configuration of the 
latter compound, the dimethyl substitution of its' amino group or a com-
bination of these. Both compounds affected the respiration in a manner 
similar to that observed with the non-ethynyl derivatives of cyclohexanol. 
trans-2-(E_-Chlorophenyl)-N, N-dimethylcyclohexylamine hydro-
chloride on the other hand, produced a presser response unrelated to 
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the three doses investigated (Fig. 3). However, the duration of the 
response was dose dependent. Respiratory activity following the inject-
ion of this compound was observed to increase, in contrast to the respir·· 
atory depression which accompanied the injection of the other cyclohexyl-
amine derivatives. 
Since the cis-N-methylcyclohexylamine was not available for test-
ing, it would be difficult to say whether the c is configuration alone is 
responsible for the greater hypotensive activity, or whether such activ-
ity is due to both the cis configuration and the N, N - dimethyl substitution 
of the compound. In the trans configuration intravenous injection of the 
secondary amine produced a depressor response, while the tertiary 
amine similarly administrated produced a pressor response. The 
cyclohexylamines (both cis and trans) previously tested by Smith (1963) 
were primary amines and all produced the characteristic drop in rat 
blood pressure. Thus, it seems likely that the pressor response elic-
ited by trans-2-(e_-chlorophenyl)-N, N-dimethylcyclohexylamine hydro-
chloride is dependent upon both the trans configuration of the compound 
and the N, N-dimethyl substitution. An attempt was made to determine 
the mechanism involved in the pressor response, the discussion of 
which appears below. 
It can.cbe su:mmarized from the statistical determination of the ED so 
(hypotensive), that the non-ethynyl derivatives of cyclohexanol were 
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2 to 7 times more potent in their ability to lower the blood pres sure of 
the intact rat, than were the derivatives of cyclohexylamine. 
In blood pressure experiments, Smookler (1961) and Smookler and 
DeFeo ( 1962) reported the production of hematuria by the cyclohexanol 
compounds investigated. Hematuria was also observed following the 
intravenous injection of the compounds presently studied. However, 
gross observation of the plasma of a mixture of heparinized dog blood 
and each compound failed to reveal hemolysis. 
The anesthetic used in this and the previous investigations above, 
was urethane. Herzog (1925) reported that urethane caused the rupture 
of red blood cells in the capillaries of the frog. Goodman and Gilman 
(1955) stated that urethane had a cytotoxic action on the blood. More 
recently, Bree and Cohen (1965) demonstrated the damaging effects of 
urethane on blood and blood vessels in rabbits. Among those described, 
hemolysis was apparent in blood sera samples drawn within two min-
utes after the induction of anesthesia. In all probability therefore, the 
he:maturia previously reported by Smookler (1961) and Smookler and 
DeFeo (1962) and presently observed by this author was not caused by 
the compounds studied, but by the anesthetic employed. 
B. ISOLATED HEART STUDIES 
The primary purpose of the investigation was to determine whether 
or not the compounds possessed cardio-inhibitory properties. Since 
1 
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all of the compounds with the exception of trans-2-(E.- chlorophenyl)-
N, N-dimethylcyclohexylamine hydrochloride produced a rapid and 
transient fall of the blood pressure in the intact rat, the possibility 
existed that such an action might be due to direct depression of the 
myocardium. Indeed, Huitric et al. (1959) observed that 2-(~-tolyl) 
cyclohexanol produced reversible mechanical cardiac arrest when 
perfused as a saturated aqueous solution through isolated cat hearts. 
Moreover, when the isomers of this compound and other aryl substi-
tution products of cyclohexanol were investigated, Smookler and 
DeFeo (1962) reported that eight of the ten compounds tested on the 
isolated guinea pig heart we re capable of producing cardiac arrest. 
All of the cyclohexylamine derivatives tested by Smith (1963) produced 
arrest of the isolated guinea pig heart, as indicated by a depression in 
the amplitude of contraction of 95 per cent or more. 
In the present investigation complete mechanical arrest of the 
isolated guinea pig heart was produced by each compound except trans-
2-~-tolyl-cis-4-hydroxy-trans-5-hydroxycyclohexanol. Due to an insuf-
ficient amount of this compound only a 10 per cent decrease in the 
amplitude of cardiac contraction in response to 1. 0 mg of the compound 
was recorded. 
Among the other cyclohexanol derivatives tested, 1-ethynyl-cis-
2-~-tolylcyclohexanol was the most potent while trans-2-::-tolyl-
85 
cis-1, 4-cyclohexanediol was the least potent . (Table XVI). Whereas no 
difference in hypotensive activity existed between trans-2-£-tolyl-cis-
l, 4-cyclohexanediol and trans-2-£-tolyl-trans- l, 5- cyclohexa nediol, 
the latter compound was found to be twice as active in producing arrest 
of the isolated guinea pig heart. 
Thus, on the isolated guinea pig heart preparation, if the hydroxyl 
substituent is moved from the four to the five position of trans-2-£-
tolylcyclohexanol the cardio-inhibitory activity of the compound is 
increased by 2 fold. Moreover, when the hydroxyl substituent is omit-
ted and an ethynyl group is substituted at the number one position of the 
compound, the cardio-inhibitory activity is increased by 3 fold. The 
activity is increased 5 fold if the latter change in structure is made on 
the cis isomer. 
l-Ethynyl-trans-2-£-tolylcyclohexanol possessed cardiotoxic 
properties indicated by the irreversible cardiac arrest produced by the 
minimum effective dose of 3. 0 mg. Unlike the reversible cardiac 
arrest produced by the other compounds, the irreversible arrest was 
characterized by an intense increase in the tone of the myocardium 
resulting in complete systolic standstill which remained until the exper-
iments were terminated at the end of ninety minutes. On the other hand, 
l-ethynyl-cis-2-£ tolylcyclohexanol did not show any signs of cardio-
toxicity with any of the dosage levels employed. The fact that only one 
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of two ethynyl derivatives of cyclohexanol possessed cardio-toxic 
properties rules out the possibility that the solvent system employed 
was responsible for this effect. Moreover, control injections showed 
the solvent to possess a transient positive inotropic effect which occur-
red concomitant to a transient decrease in the ton e of the myocardium. 
It should be noted, that with the ethynyl compounds the duration of 
arrest and recovery time were more prolonge d than were tho se of the 
other cyclohexanol derivatives tested. 
In general, a dose-related response to the cyclohexanol derivatives 
on the isolated guinea pig heart was found to exist with regard to the 
duration of the cardiac arrest and to the per cent depression in ampli-
tude of contraction produced when no arrest occurred (Tables IX to XII). 
The antagonistic effect of various calcium ion concentrations on 
the negative inotropic response to 1. 0 mg of 1- ethynyl-cis-2-_£-tolyl-
cyclohexanol was investigated (Fig. 7). In all cases when injected 
during cardiac arrest calcium produced a transient positive inotropic 
response. Since the heart was continuously perfused, the calcium was 
rapidly washed from the tissue and the condition of cardiac arrest 
which existed prior to the calcium administration was resumed. 
The cyclohexylamine hydrochloride derivatives were the most 
potent of all the compounds tested on the isolated guin ea pig hea r t 
(Table XVI). From the table, little difference in cardio-inhibitory 
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activity exists between the trans and cis isomers of 2-(e.-chlorophenyl)-
N, N-dimethylcyclohexylamine hydrochloride. However, both of these 
compounds were approximately 25 per cent more active than was trans-
2-(E_-chlorophenyl)-N-methylcyclohexylamine hydrochloride based on 
the calculated ED95 (cardio-inhibitory). The negative inotropic re -
sponse occurring in the absence of arrest was approximately the same 
for all three compounds; however, the pe r i o d of arrest and recovery 
time were both of longer duration following the administration of cis-2-
(.E_-chlorophenyl)-N, N-dimethylcyclohexylamine hydrochloride (Tables 
XIII to XV). Smookler and DeFeo ( 1962) reported that the chlorophenyl 
substituted derivatives of cyclohexanol possessed cardio-toxic proper-
ties as evidence by the failure of most of the hearts studied to recover 
from the effects of these compounds. On this basis, none of the chloro-
phenyl substituted derivatives of cyclohexylamine presently investigated 
exhibited cardiotoxicity. 
It will be recalled that trans-2-(.E_-chlorophenyl)-N, N-dimethyl -
cyclohexylamine hydrochloride produced a response on the blood pres-
sure of the intact rat completely opposite to that produced by its' isomer. 
Nevertheless, the two isomers were equally potent and the most active 
compounds in producing arrest of the isolated guinea pig heart. 
The effects of the cyclohexylamine hydrochloride salts on the rate 
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of coronary flow were studied by recording the time required to collect 
1. 0 ml. of effluent perfusate. The trans isomers of the tertiary amine 
and the secondary amine showed a time increase over control values of 
100 per cent and of 88 per cent respectively. Thus, these compounds 
also increase coronary vascular resistance in conjunction with their 
negative inotropic effects. 
On the basis of the calculated ED95 (cardio-inhibitory) of the 
cyclohexanol and cyclohexylamine derivatives (Table XVI), the cyclo-
hexylamine derivatives were up to 8 times more potent than were the 
cyclohexanol derivatives. Only a slight difference in activity existed 
among the three cyclohexylamines tested, while as much as a 5 fold 
variation in activity existed between the cyclohexanol derivatives. Both 
the cationic amino group and the chloro substituent on the aromatic ring 
may account for the greater activity of the cyclohexylamine hydro-
chloride salts. 
The ethynyl derivatives were the most active of the cyclohexanol 
compounds. However, the minimum effective dose of the trans isomer 
was also the cardio-toxic dose. From the effects produced by the other 
cyclohexanol derivatives on the isolated guinea pig heart it is apparent 
that the presence of additional hydroxyl substituents on the cyclohex-
anol ring (specifically at the four and/or five positions) is responsible 
for the decrease in activity associated with these compounds. 
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C. ISOLATED ATRIAL STUDIES 
Preliminary mechanism and site of action studies were performed 
on spontaneously beating isolated rat atria. Smookler and DeFeo (1962) 
reported that trans-2-(£_-tolyl) cyclohexanol was immediately effective 
in reducing the contraction amplitude of isolated rabbit atria without 
affecting the rate. The investigators further observed that the calcium 
ion antagonized this effect by restoring the amplitude to a normal level. 
In the present study, trans-2-£_-tolyl-trans - l , 5-cyclohexanediol 
similarly depressed the contraction amplitude of isolated rat atria 
without affecting the rate. Likewise, the amplitude was quic kly re -
stored to a control level by the administration of calcium (Fig. 12). 
Antagonism between the compound and the calcium ion was also demon-
strated when both were administered simultaneously. The resulting 
increase in amplitude was only two thirds of that produced when calcium 
the duration of the peak effect were also reduced. l was added alone. In addition, the rate of the increase in amplitude, and 
cis-2-(£-Chlorophenyl)-N, N-dimethylcyclohexylamine hydrochlo ,.,. 
ride produced both negative inotropic and chronotr opic effects on the 
isolated rat atria. The decrease in contraction amplitude was preceded 
in all instances by a positive inotropic response. The duration of this 
response was shorter when the dose of the compound was increased. 
In the unpublished work by Smith (1963) the cyclohexylamines investi gated. 
reportedly increased the contraction amplitude of rat atria while 
decreasing the rate. The negative inotropic effect was not observed, 
since the investigator allowed only a three minute period of tissue 
exposure before washing the preparation. 
Iii.the present study, the negative inotropic effect did not appear 
until after tP.ree minutes, although the negative chronotropic effect 
progressed throughout the entire exposure time. Calcium was able 
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to restore the amplitude to control level but unable to restore the rate 
(Fig. 13). 
Since the compound and the calcium salts each produced a positive 
inotropic response within ninety seconds, it seemed likely, that if both 
were administered together, a summation of the responses would occur 
within this time. This was not demonstrated and the delayed positive 
inotropic response which did occur was of the same magnitude as that 
produced by the compound .alone. Moreover, after a slight increase , 
the rate of contraction diminished in a manner similar to that observed 
when the compound was given alone . 
Thus, on the isolated rat atria and with the concentrations employ-
ed, the cyclohexanol derivative affected the force of contraction while 
both the force and rate of contraction were affected by the cyclohexyl-
amine derivative. Calcium antagonized the negative inotropic effects 
of the compounds when administered after these had occurred. The 
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onset of the inotropic effect of each compound was delayed by the cal-
cium if both were given simultaneously. However, the cation was -
unable to overcome the negative chronotropic response to the cyclo-
hexylamine derivative. 
The results obtained with the cyclohexanol derivative support 
the observations of Smookler and DeFeo (1962). The negative inotropic 
and chronotropic effects produced by the cyclohexylamine derivative 
indicate a possible quinidine-like action on the myocardium. Conn and 
Luchi (1964) point out that the most critical reactive site in the quini-
dine molecule is the tertiary nitrogen. The investigators also specu-
late that quinidine chelation of calcium may underlie its' depressant 
effects on myocardial contractility. 
In view of the recent emphasis on calcium as the critical media-
tor of excitation-contraction coupling, and the antagonism demonstrated 
investigated, it seems probable that chelation of calcium may be of 1 
between calcium and the inotropic action of the compounds presently 
significance in the action of these compounds. 
D. PRELIMINARY INVESTIGATION OF THE PRESSOR RESPONSE TO 
(TH-25 ). 
Despite the pressor activity of trans-2(E.-chlorophenyl)-N ,, N-
dimethylcyclohexylamine hydrochloride, the compound was the most 
potent in arresting the isolated guinea pig heart. In view of these 
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findings, additional blood pressure experiments were carried out in 
an effort to understand more completely the mechanism involved in the 
pressor response. 
The first of these experiments failed to indicate that baroreceptor 
activity might have induced reflex vasoconstriction. Hexamethonium 
prevented the pressor response to carotid occlusion but did not affect 
the responses to epinephrine or the compound (Figs. 14 and 15). The 
second experiment demonstrated that the depletion of catecholamine 
stores by reserpine did not alter the compounds pressor activity. The 
only significant change in the pressor response occurred when the 
compound was injected after the administration of dibenamine (Figs. 
16 and 17). Due to an insufficient supply of the compound, the mechan-
ism involved in the pressor response was pursued no further. 
However, from these results and those previously obtained from 
the isolated heart and blood pressure experiments, it is indicated that 
the pressor response to the intravenous injection of trans-2-(E.-chloro-
phenyl)-N, N-dimethylcyclohexylamine hydrochloride stems from the 
compounds ability to produce peripheral vasoconstriction. The inter -
pretation is supported somewhat, by Marsh (1948) who reported that 
certain cyclohexylalkylamines passes sed pres sor activity. Moreover, 
Fellows et al. (1950) showed the increase in blood pressure produced 
by the cyclohexylalkylamines studied was due to increased peripheral 
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vasoconstrictor activity. 
E. CORRELA TIO NS 
Molecular structure and spatial configuration influenced the 
relative cardiovascular activity of the compounds studied. An inverse 
relationship existed between a compound's ability to arrest the isolated 
guinea pig heart, and its' ability to lower the blood pressure of the 
intact rat. The cyclohexylamine derivatives which were the most active 
in the former group of experiments were the least active in the latter 
group; in one instance a pressor response occurred. A decrease in 
coronary flow accompanied the cardioplegic activity of the cyclohexyl-
amine compounds. Whether or not this was a direct effect of the com-
pound, on the coronary vasculature, was not determined. On the basis 
of recovery from induced cardiac arrest, only one compound was cardio -
toxic. 
Calcium was able to momentarily restore contraction of the heart 
arrested by one of the cyclohexanol derivatives; and in the isolated atria, 
calcium antagonized the negative inotropic effects of representatives 
from both series of compounds. The cyclohexylamine compound also 
possessed a negative chronotropic affect on the isolated atria, which 
was unaltered by the calcium administration. 
In view of the isolated heart and atrial experiments, cyclohexanol 
cardioplegia appears to result from an alteration in the electrolyte 
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balance thereby modifying the contraction of the myocardium. On the 
other hand , the cyclohexylamine cardioplegia appears to result from 
either altered impulse formation, or suppressed impulse conduction , 
in addition to the decrease in contraction of the myocardi um menti one d 
above. Under these conditions, it might also be expected that eventual 
atria-ventricular dissociation could bring about the observed asystole . 
To definitely understand the mechanism of the observed cardioplegia, 
electrocardiograms and transmembrane potentials should be recorded 
in conjunction with the isolated tis sue experiments. 
Although beyond the scope of the investigation, preliminary 
studies indicated that the pressor response to one of the cyclohexyl -
amine derivatives resulted from the compounds direct action on the 
peripheral vasculature. Further experimental evidence is needed to 
confirm this. 
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V. SUMMARY AND CONCLUSIONS 
A. A series of synthetic chemical compounds were pharmacologically 
screened for cardioplegic and hypotensive activity with the purpose of 
relating such activity to the structural arrangement of the compounds 
and to attempt to determine the mechanism through which the compounds 
acted. 
B. As a group, the non-ethynyl cyclohexanol derivatives were 2 to 7 
times more potent than were the derivatives of cyclohexylamine in 
producing a hypotensive response in the intact rat. trans-2-£-Tolyl -
cis-l, 4-cyclohexanediol and trans-2-£-tolyl - trans - l, 5-cyclohexanediol 
were equally effective and the most active, while the trans isomer of 
the tertiary cyclohexylamine was the least active and the only compound 
that produced a pressor response. 
C. The cyclohexylamine derivatives were up to 8 times more potent 
in arresting the isolated guinea pig heart, than were the derivatives of 
cyclohexanol. The cis and trans isomers of the tertiary cyclohexyl-
amine were equally effective and the most active; while trans -2-£-
tolyl-cis-l, 4-cyclohexanediol possessed the least amount of cardio-
inhibitory activity among those compounds studied. 
D. An increase in the number of hydroxy substituents on the cyclo-
hexanol ring was accompanied by a decrease in both hypotensive and 
cardio-inhibitory activity. 
E. The minimum effective dose of l -ethynyl-trans-2-£_-tolylcyclo -
hexanol in producing cardiac arrest was also the cardio-toxic dose; 
while the cis isomer showed the greatest cardio-inhibitory activity 
among the cyclohexanol derivatives studied. 
F. Spatial configuration was also significant in the blood pressure 
activity of the tertiary cyclohexylamines. The cis isomer produced 
a depressor response in contrast to the pressor response elicited by 
the trans isomer. 
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G. In the isolated atrial preparation, calcium antagonized the negative 
inotropic effects of trans-2-£_-tolyl-trans-l, 5-cyclohexanediol and cis-
2-(E_-chlorophenyl)-N, N-dimethylcyclohexylamine hydrochloride. 
Moreover, calcium momentarily restored contraction of the heart 
arrested by l-ethynyl-cis-2-£.-tolylcyclohexanol. 
H. In addition to its' negative inotropic effect on the isolated atria, 
cis-2-(E_-chlorophenyl)-N, N-dimethylcyclohexylamine hydrochloride 
also produced a negative chronotropic response which was unaffected 
by the administration of calciurn. 
I. Decreased contraction of the myocardium appears to be responsible 
for the cardioplegia produced by the cyclohexanol compounds, since the 
pacemaker activity of the isolated atrial preparation is not affected. 
J. In addition to a decreased contraction of the myocardium, alteration 
of impulse formation or suppression of impulse conduction appear to be 
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responsible for the cardioplegia produced by the cyclohexylamine 
derivatives. 
K. Preliminary studies of the pressor response to trans-2-(.E_-chloro -
phenyl)-N, N-dimethylcyclohexylamine hydrochloride indicate that the 
compound is capable of producing peripheral vasoconstriction. 
L. It was suggested that the appearance of hematuria at the conclusion 
of the blood pressure experiments occurred as a result of the blood 
damaging and cytotoxic properties of the anesthetic agent, and was not 
an effect of the compounds investigated. 
M. The implications of these findings, and the r elationship between 
chemical structure and activity are discussed. 
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